{"result": "(\"entity\"<|>PACIENTES<|>PERSON<|>Patients are individuals who may experience conditions like chylothorax and require treatment interventions.)\n##\n(\"entity\"<|>FÍSTULAS<|>EVENT<|>Fistulas are abnormal connections that can occur in the lymphatic system, leading to conditions like chylothorax.)\n##\n(\"entity\"<|>DESNUTRICIÓN<|>EVENT<|>Malnutrition is a potential complication resulting from significant lymphatic fluid loss in conditions like chylothorax.)\n##\n(\"entity\"<|>TRATAMIENTO CONSERVADOR<|>EVENT<|>Conservative treatment refers to non-surgical management strategies for conditions like chylothorax.)\n##\n(\"relationship\"<|>PACIENTES<|>DESNUTRICIÓN<|>Patients with chylothorax may experience malnutrition due to significant lymphatic fluid loss.<|>6)\n##\n(\"relationship\"<|>FÍSTULAS<|>QUILOTÓRAX<|>Fistulas can lead to the development of chylothorax by creating abnormal connections in the lymphatic system.<|>5)\n##\n(\"relationship\"<|>TRATAMIENTO CONSERVADOR<|>QUILOTÓRAX<|>Conservative treatment is often the first approach for managing chylothorax before considering surgical options.<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: es la etilnefrina20, 39,                        El  shunt portosistémico transyugular intrahepático\nfármaco simpaticomimético que reduce el flujo linfáti-                          (TIPS) 40 es de utilidad en el quilotórax secundario a\nco en el conducto torácico por contracción de la mus-                           hipertensión portal que puede resolverlo espontánea-\nculatura lisa de su pared. Debe utilizarse con mucha                            mente. La linfografia también puede ser útil en los qui-\nprecaución e incluso está contraindicada en pacientes                           lotórax no traumáticos con resolución entre el 6 y el\ncon vasculopatía por sus efectos adversos.                                      50% de los casos, aunque esta técnica no es conside-\n   En líneas generales, el porcentaje de resolución con                         rada propiamente como una terapia41, 42.\ntratamiento conservador puede alcanzar hasta más del                              La embolización percutánea del conducto torácico o\n75%, para pérdidas inferiores a 1.000 ml. Cuando las                            de la fístula linfática43, 44 puede realizarse en adultos y\npérdidas son superiores a 1.000 ml las posibilidades de                         en niños y se plantea como una buena alternativa a la\néxito con tratamiento conservador son bajas. La dura-                           ligadura quirúrgica del conducto torácico. Sus resulta-\nción del tratamiento conservador habitualmente debe                             dos pueden alcanzar una resolución del proceso en el\nmantenerse de 7 a 14 días20, 23, 24.                                            90 -100% de los casos traumáticos. Esta técnica puede\n                                                                                resolver una fístula no solucionada con tratamiento\n5.2.   Tratamiento quirúrgico                                                   quirúrgico. En los casos que la causa es no traumática,\n                                                                                los resultados son inferiores pero pueden alcanzar el\n   El tratamiento quirúrgico se recomienda en los casos                         52% de los casos. Cuando no es posible la emboliza-\nrefractarios al tratamiento conservador, especialmente                          ción del conducto torácico por variantes anatómicas,\nen las fístulas de alto débito. No existe consenso ni estu-                     se puede realizar una disrupción percutánea de los va-\ndios controlados respecto a cuándo es el momento indi-                          sos linfáticos para reducir el flujo de linfa. Los resulta-\ncado para realizarlo, pero se ha sugerido que este debe-\nría realizarse en las siguientes condiciones4, 5, 20, 21, 23:                   dos son inferiores a la embolización, aproximadamente\n                                                                                se resuelven un tercio de los pacientes45.\n                                                                                  La embolización tiene una baja tasa de complicaciones,\n   •  Si las pérdidas del drenaje linfático son > 1-1,5 l/                      alrededor del 3% y ninguna fatal, por lo que se le puede\n      día.                                                                      considerar una técnica intervencionista bastante segura.\n   •  Persistencia de pérdidas > 1 l/día después de\n      5 días de tratamiento conservador.                                        6.   Resumen y conclusiones\n   •  Fístula persistente > 2 semanas.\n   •  Pérdidas por drenaje sin cambios durante 1-2 se-                            El quilotórax y la ascitis quilosa son entidades poco\n      manas.                                                                    frecuentes caracterizadas por el acúmulo de linfa en la\n   •  Deterioro clínico del paciente: desnutrición, com-                        cavidad pleural o peritoneal. Pueden producirse por le-\n      plicaciones metabólicas.                                                  siones primarias o congénitas del sistema linfático o\n                                                                                adquiridas secundariamente a traumatismos postqui-\n   El tratamiento quirúrgico primario irá dirigido a re-                        rúrgicos, neoplasias primarias del sistema linfático o\nparar la lesión del conducto linfático lesionado me-                            metastásicas en el mediastino o en el peritoneo.\ndiante ligadura. Se recomienda el tratamiento quirúr-                             El quilotórax, la ascitis quilosa o la linforragia suponen\ngico precoz en pacientes jóvenes, en aquellos con                               una pérdida importante de proteínas, grasas y linfocitos\nfístulas de alto débito y en niños con peso inferior a                          que pueden conducir a una situación de desnutrición. El\n4 kg. La tasa de resultados positivos se sitúa en el 90-95%                     tratamiento de estas entidades será inicialmente conser-\ncuando el conducto torácico puede ser identificado.                             vador basado en una dieta modificada en TCL, con res-\n   Otros tratamientos quirúrgicos con carácter paliativo                        tricción de la grasa hasta un 20% del contenido energé-\nson el talcaje pleural o el shunt pleuroperitoneal en el                        t\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ETILNEFRINA<|>ORGANIZATION<|>Etilnefrina is a sympathomimetic drug that reduces lymphatic flow in the thoracic duct by contracting the smooth muscle of its wall.)\n##\n(\"entity\"<|>SHUNT PORTOSISTÉMICO TRANSYUGULAR INTRAHEPÁTICO<|>EVENT<|>The transjugular intrahepatic portosystemic shunt (TIPS) is a procedure useful in treating chylothorax secondary to portal hypertension.)\n##\n(\"entity\"<|>QUILOTÓRAX<|>EVENT<|>Chylothorax is a rare condition characterized by the accumulation of lymph in the pleural cavity.)\n##\n(\"entity\"<|>HIPERTENSIÓN PORTAL<|>EVENT<|>Portal hypertension is a condition that can lead to chylothorax and is associated with various complications.)\n##\n(\"entity\"<|>LINFOGRAFÍA<|>EVENT<|>Lymphography is a technique that may be useful in non-traumatic chylothorax cases with a resolution rate of 50%.)\n##\n(\"entity\"<|>EMBOLIZACIÓN<|>EVENT<|>Percutaneous embolization of the thoracic duct or lymphatic fistula is a procedure that can be performed in adults and children.)\n##\n(\"entity\"<|>TRATAMIENTO QUIRÚRGICO<|>EVENT<|>Surgical treatment is recommended in cases refractory to conservative treatment, especially in high-output fistulas.)\n##\n(\"entity\"<|>DRENAJE LINFÁTICO<|>EVENT<|>Lymphatic drainage refers to the process of removing lymph fluid from the body, which can be affected in conditions like chylothorax.)\n##\n(\"relationship\"<|>ETILNEFRINA<|>QUILOTÓRAX<|>Etilnefrina is used to reduce lymphatic flow, which is relevant in the treatment of chylothorax.<|>7)\n##\n(\"relationship\"<|>SHUNT PORTOSISTÉMICO TRANSYUGULAR INTRAHEPÁTICO<|>QUILOTÓRAX<|>The TIPS procedure is useful in treating chylothorax secondary to portal hypertension.<|>8)\n##\n(\"relationship\"<|>QUILOTÓRAX<|>HIPERTENSIÓN PORTAL<|>Chylothorax can occur as a complication of portal hypertension.<|>6)\n##\n(\"relationship\"<|>LINFOGRAFÍA<|>QUILOTÓRAX<|>Lymphography may be useful in diagnosing non-traumatic chylothorax cases.<|>5)\n##\n(\"relationship\"<|>EMBOLIZACIÓN<|>QUILOTÓRAX<|>Embolization is a treatment option for chylothorax, especially in cases where conservative treatment fails.<|>7)\n##\n(\"relationship\"<|>TRATAMIENTO QUIRÚRGICO<|>QUILOTÓRAX<|>Surgical treatment is indicated for high-output chylothorax cases that do not respond to conservative measures.<|>8)\n##\n(\"relationship\"<|>DRENAJE LINFÁTICO<|>QUILOTÓRAX<|>Lymphatic drainage is a key factor in the management of chylothorax.<|>6)\n<|COMPLETE|>"}]}